Advertisement
Screener

Penumbra, Inc (PEN) Graph

PEN Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $390.05M; Cost of revenue $125.10M; Research and development (m); Selling, general and administrative $198.51M.
  • 2026-03-31: Revenue $374.76M; Cost of revenue $121.35M; Research and development (m); Selling, general and administrative $192.79M.
  • 2025-12-31: Revenue $385.38M*; Cost of revenue $123.26M*; Research and development (m); Selling, general and administrative $181.10M*.
  • 2025-09-30: Revenue $354.69M; Cost of revenue $114.27M; Research and development (m); Selling, general and administrative $168.90M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PEN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.EmbolizationAnd Access$131.06MThrombectomy$258.98MRevenue$390.05MCost of revenue$125.10MGross profit$264.94MOperating expenses$223.90MOperating income$41.04MOther income, net-$456.00KSelling, general& administrative$198.51MPre-tax income$46.19MNet income$34.81M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PEN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$84.60MUS$305.44MRevenue$390.05MCost of revenue$125.10MGross profit$264.94MOperating expenses$223.90MOperating income$41.04MOther income, net-$456.00KSelling, general& administrative$198.51MPre-tax income$46.19MNet income$34.81M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$390.05M$125.10M(m)$198.51M$223.91M$11.38M$34.81M
2026-03-31$374.76M$121.35M(m)$192.79M$215.18M$9.10M$32.58M
2025-12-31$385.38M*$123.26M*(m)$181.10M*$202.90M*$16.29M*$47.34M*
2025-09-30$354.69M$114.27M(m)$168.90M$191.58M$6.47M$45.85M
2025-06-30$339.45M$115.44M(m)$159.96M$183.18M$40.00K$45.27M
2025-03-31$324.14M$108.26M(m)$153.46M$175.53M$4.63M$39.22M
2024-09-30$301.04M$100.73M(m)$139.74M$164.94M$10.25M$29.53M
2024-06-30$299.40M$136.57M(m)$141.90M$243.79M-$17.67M-$60.20M
2024-03-31$278.65M$97.52M(m)$144.41M$169.04M$3.62M$11.00M
2023-12-31$284.68M$97.69M(m)(m)$151.96M-$16.06M$54.22M
2023-09-30$270.95M$93.23M(m)$125.92M$165.09M$4.09M$9.21M
2023-06-30$261.50M$94.64M$21.54M$127.44M$148.97M$576.00K$18.96M
2023-03-31$241.40M$90.33M$19.99M$123.08M$143.06M$90.00K$8.56M
2022-12-31$221.22M$82.79M(m)(m)$133.59M$3.25M$3.88M
2022-09-30$213.68M$78.35M$21.32M$108.57M$129.89M$5.31M-$2.27M
2022-06-30$208.34M$74.31M$19.56M$114.61M$134.17M$2.52M-$3.69M
2022-03-31$203.90M$76.48M$20.56M$110.90M$131.46M-$5.18M$79.00K
2021-12-31$204.01M$78.56M(m)(m)$165.50M-$16.32M-$24.63M
2021-09-30$190.12M$70.20M$16.73M$94.40M$111.13M-$249.00K$8.85M
2021-06-30$184.26M$65.57M$17.74M$90.64M$108.37M$1.90M$9.23M
2021-03-31$169.20M$57.87M$18.08M$79.80M$97.87M$1.54M$11.84M
2020-12-31$166.90M$72.58M(m)(m)$96.06M-$3.14M$3.65M
2020-09-30$151.08M$60.15M$34.92M$76.16M$111.08M-$9.86M-$8.81M
2020-06-30$105.11M$40.18M$22.73M$59.85M$82.58M-$4.13M-$11.96M
2020-03-31$137.33M$49.32M$12.95M$74.45M$87.40M-$1.63M$1.43M
2019-12-31$145.26M$47.13M(m)(m)$87.55M$2.45M$9.69M
2019-09-30$139.50M$43.50M$13.73M$69.29M$83.02M$1.96M$11.48M
2019-06-30$134.20M$40.27M$13.46M$67.67M$81.13M-$2.73M$16.59M
2019-03-31$128.44M$44.53M$11.67M$61.09M$72.76M$1.46M$10.70M
2018-12-31$120.79M$42.08M(m)(m)$72.04M$885.00K$6.66M
2018-09-30$111.81M$36.79M$9.09M$55.93M$95.86M$1.60M-$18.93M
2018-06-30$109.64M$37.39M$8.19M$54.78M$62.97M-$4.95M$13.38M
2018-03-31$102.70M$36.14M$8.01M$54.50M$62.51M-$1.94M$5.49M
2017-12-31$96.05M$32.32M(m)(m)$59.87M-$5.90M$9.08M
2017-09-30$83.91M$29.13M$8.13M$45.96M$54.09M$456.00K$238.00K
2017-06-30$80.59M$29.66M$8.09M$44.16M$52.26M$482.00K-$1.56M
2017-03-31$73.21M$25.50M$7.03M$42.72M$49.76M$1.35M-$3.11M
2016-12-31$73.11M$26.52M(m)(m)(m)$881.00K-$2.40M
2016-09-30$67.19M$24.31M$6.50M$37.74M$44.24M-$13.00M$11.91M
2016-06-30$65.11M$23.64M$6.26M$35.88M$42.14M-$3.40M$3.01M
2016-03-31$57.92M$18.01M$5.00M$33.07M$38.07M-$170.00K$2.29M
2015-12-31$54.42M$17.96M(m)(m)(m)(m)$1.63M
2015-09-30$50.42M$16.92M$4.56M$26.75M$31.32M$1.18M$901.00K
2015-06-30$42.31M$14.94M$4.79M$26.40M$31.19M-$1.51M-$2.67M
2015-03-31$38.95M$12.22M$3.19M$19.55M$22.74M$1.74M$2.50M
2014-12-31$35.40M$11.51M(m)(m)(m)(m)$416.00K
2014-09-30$32.46M$11.67M$3.90M$16.59M$20.49M$227.00K$172.00K
2014-06-30$31.48M$10.78M(m)(m)(m)(m)$391.00K
2014-03-31$26.16M$8.71M(m)(m)(m)(m)$1.27M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$764.80M$246.45M(m)$391.30M$439.08M$20.48M$67.39M
2025-06-30$663.60M$223.70M(m)$313.42M$358.71M$4.67M$84.49M
2024-06-30$578.06M$234.09M(m)$286.31M$412.83M-$14.05M-$49.20M
2023-06-30$502.90M$184.96M$41.52M$250.51M$292.04M$666.00K$27.52M
2022-06-30$412.24M$150.79M$40.12M$225.51M$265.64M-$2.66M-$3.61M
2021-06-30$353.46M$123.44M$35.81M$170.43M$206.25M$3.44M$21.07M
2020-06-30$242.44M$89.50M$35.67M$134.31M$169.98M-$5.76M-$10.54M
2019-06-30$262.64M$84.80M$25.13M$128.76M$153.88M-$1.28M$27.29M
2018-06-30$212.34M$73.53M$16.21M$109.28M$125.48M-$6.89M$18.87M
2017-06-30$153.80M$55.16M$15.13M$86.88M$102.01M$1.84M-$4.66M
2016-06-30$123.03M$41.65M$11.27M$68.94M$80.21M-$3.57M$5.30M
2015-06-30$81.26M$27.16M$7.98M$45.94M$53.93M$233.00K-$169.00K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$1.02B$337.97M(m)$482.32M$550.29M$11.15M$130.34M
2024-09-30$879.10M$334.82M(m)$426.05M$577.77M-$3.80M-$19.67M
2023-09-30$773.84M$278.19M(m)$376.43M$457.13M$4.76M$36.74M
2022-09-30$625.92M$229.14M$61.44M$334.09M$395.53M$2.64M-$5.88M
2021-09-30$543.58M$193.64M$52.55M$264.83M$317.38M$3.20M$29.92M
2020-09-30$393.51M$149.65M$70.59M$210.47M$281.06M-$15.62M-$19.35M
2019-09-30$402.14M$128.31M$38.86M$198.04M$236.91M$683.00K$38.77M
2018-09-30$324.14M$110.32M$25.30M$165.21M$221.34M-$5.29M-$58.00K
2017-09-30$237.71M$84.30M$23.26M$132.85M$156.11M$2.29M-$4.43M
2016-09-30$190.21M$65.96M$17.76M$106.69M$124.45M-$16.56M$17.21M
2015-09-30$131.68M$44.08M$12.54M$72.70M$85.24M$1.42M$732.00K
2014-09-30$90.11M$31.16M$11.44M$44.83M$56.26M$893.00K$1.83M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$1.40B$461.23M(m)$663.42M$753.19M$27.44M$177.69M
2024-12-31$1.19B$439.62M(m)$573.99M$745.72M$6.86M$14.01M
2023-12-31$1.06B$375.88M(m)$506.45M$609.09M-$11.30M$90.95M
2022-12-31$847.13M$311.93M(m)$449.72M$529.13M$5.89M-$2.00M
2021-12-31$747.59M$272.21M(m)$378.33M$482.88M-$13.13M$5.28M
2020-12-31$560.41M$222.24M(m)$287.07M$377.12M-$18.76M-$15.70M
2019-12-31$547.40M$175.44M(m)$272.73M$324.46M$3.13M$48.46M
2018-12-31$444.94M$152.41M$36.16M$226.38M$293.38M-$4.40M$6.60M
2017-12-31$333.76M$116.62M$31.66M$184.32M$215.98M-$3.61M$4.66M
2016-12-31$263.32M$92.49M$23.88M$148.30M$172.18M-$15.68M$14.81M
2015-12-31$186.09M$62.04M$18.03M$101.85M$119.88M$1.66M$2.37M
2014-12-31$125.51M$42.67M$15.57M$64.26M$79.83M$894.00K$2.25M
2013-12-31$88.85M$30.97M$14.08M$44.92M$59.00M-$5.35M$4.10M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Solventum Corp (SOLV)United States$15.085B9.16
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B